Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Noguchi, Hirohito, Suzuki, Mitsuyuki, Hirosawa, Hiroshi, Imai, Michitaka, Mitobe, Yuta, Yoshida, Toshiaki
Publicado 2021

Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Mitobe, Yuta, Yamada, Etsuko, Abeywickrama, Hansani Madushika, Kikuchi, Yuko, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Yu
Publicado 2019

Comparison of Ablation Volume Between Emprint(®) and Mimapro(®) Systems for Hepatocellular Carcinoma –A Preliminary Study

por Ishikawa, Toru, Hasegawa, Iori, Hirosawa, Hiroshi, Honmou, Tsubasa, Sakai, Nobuyuki, Igarashi, Takanori, Yamazaki, Shun, Kobayashi, Takamasa, Sato, Toshifumi, Iwanaga, Akito, Sano, Tomoe, Yokoyama, Junji, Honma, Terasu
Publicado 2023

Effect of levocarnitine administration in patients with chronic liver disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki
Publicado 2020